Viewing Study NCT06523296



Ignite Creation Date: 2024-10-25 @ 7:59 PM
Last Modification Date: 2024-10-26 @ 3:36 PM
Study NCT ID: NCT06523296
Status: RECRUITING
Last Update Posted: None
First Post: 2024-07-23

Brief Title: Presence of Anti-RACH Antibodies and Neurocognitive Disorder in Myasthenic or Alzheimerss Patients
Sponsor: None
Organization: None

Study Overview

Official Title: Study of the Relationship Between the Presence of Anti-AChR Antibodies in the Cerebrospinal Fluid and the Presence of Neurocognitive Disorder in Myasthenic and Alzheimerss Patients
Status: RECRUITING
Status Verified Date: 2024-09
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: No
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ARN-MA
Brief Summary: The purpose of the study is to evaluate if there is a specific association between the presence of anti Rach antibodies in the CSF and the presence of a cogntive disorder in myasthenic patients Moreover the investigator wants to study if there is a link between the presence of Anti RACH antibodies in myasthenia and Alzheimerss disease

For that the investigator will recruit myasthenic patient with cognitive disorder that has undergo a diagnostic process including lombar punction for memory trouble in Nice memory center as well as Alzheimers patient having go through the same process

The study will consist in one additionnal blood draw Anti RACH antibodies will be analyzed in historical CSF stored in biocollection and serum collected for the study

LCS of healthy control will also be analyzed
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None